A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients

Autor: Rahko, E, Blanco, G, Soini, Y, Bloigu, R, Jukkola, A
Zdroj: In European Journal of Cancer 2003 39(4):447-453
Databáze: ScienceDirect